scholarly journals Prevention of Social Stigma Related to Coronavirus Disease 2019 (COVID-19)

2021 ◽  
Vol 8 (3) ◽  
pp. 93-94
Author(s):  
Arash Aliasghari ◽  
Marzieh Hossini ◽  
Fatemeh Rahimi ◽  
Kazhal Mobaraki ◽  
Jamal Ahmadzadeh

As a result of the global crisis related to coronavirus disease 2019 (COVID-19), confusion, anxiety, fear, and some psychological effects have been created among the general population in this global village. Unfortunately, these factors have provoked inappropriate behavior converting the infection to the virus to a social stigma, which can affect the dignity of people died due to COVID-19. In addition to the patient, the stigma can also affect interpersonal relationship among nurses, family members, friends, as well as social relationships. In this critical situation, we need to take care of each other with empathy, which is the key to successfully cope with the issue and prevent social stigma associated with COVID-19. This commentary evaluates the effects of social stigma related to COVID-19 and suggests some practical measures for the world communities to deal with this global public health problem.

2021 ◽  
Vol 9 (9) ◽  
pp. 2144-2150
Author(s):  
Shivam Kumar Nigam ◽  
Rita Singh ◽  
Sanjay Srivastava

Pandu Roga is one of the diseases mentioned in Ayurveda characterized by the changes in the skin colour to white (Shweta), yellowish (Peeta), greenish (Harita) etc. which is one of the “Varnopalakshita Roga" i.e., a disease characterized by the change in the colour. The clinical condition of Pandu in Ayurveda can be co-related with Anaemia described in Modern Medical Science, due to the resemblance in the clinical signs and symptoms. In Modern Medicine, Pandu is a pale appearance which may be due to the decreased blood supply to the skin or de- creased visibility of oxyhemoglobin. Anaemia is a major global public health problem and the most prevalent nu- tritional deficiency disorder in the world. This article presents the Ayurvedic concept of Pandu Roga (Anaemia). Keywords: Pandu, Vyadhi, Srotas, Anaemia, Pallor,


Author(s):  
Sameer Sharma ◽  
◽  
Chourasiya R ◽  
Susha D ◽  
◽  
...  

The COVID-19, or also called SARS-CoV-2, which is causative agent of probably inevitable disease which is of big global public health problem. COVID-19 is a positive stranded RNA virus that is majorly found in wildlife & humans. And the outbreak of Novel Coronavirus is unleashing chaos across the world due to inadequate risk assessment with reference to insistence of problem. The COVID-19 pandemic has enrolled in a critical novel phase. When compared to MERS & SARS, SARS-CoV-2 has transmitted more rapidly, because of increased globalization and adaptation of Novel coronavirus. However, the recent outbreak of COVID-19 showing an immediate requirement for therapeutics targeting SARS-CoV-2. Here, we have discussed the different symptoms in COVID-19, SARS, MERS & common flu as well as structure of virus regarding its immune response and we are providing a brief about the Indian traditional plants as conceivable novel therapeutic pathways.


2022 ◽  
pp. 389-411
Author(s):  
Rafael Vargas-Bernal

Since the end of 2019, the SARS-CoV-2 virus, commonly known as COVID-19, has become an infectious disease that has produced a severe global public health problem that requires solutions from different scientific initiatives. Nanomaterials are used to diagnose, treat, and prevent the SARS-CoV-2 virus. Its potential is highlighted through specific applications and developments carried out by researchers around the world. In addition to highlighting the characteristics and properties of the COVID-19 virus, the purpose of the chapter is focused on describing the role that nanomaterials are playing and that must be overcome due to the pandemic. Future research directions are described to guide readers on the innovations that are required related to the diagnosis, treatment, and prevention of SARS-CoV-2 and its variants. The impact that nanomaterials will have on COVID-19 will reduce the time for humans to return to the rhythm of life before the pandemic.


2011 ◽  
Vol 12 (1) ◽  
pp. 21-28 ◽  
Author(s):  
Americo Cicchetti ◽  
Matteo Ruggeri ◽  
Paola Codella ◽  
Alessandro Ridolfi

Chronic kidney disease is growing as a global public health problem throughout the world. In Italy, CKD is becoming increasingly common with 52,777 patients treated with dialysis in 2010, about 10,000 new patients/years in dialysis from 2010.  The impact on the health care system includes € 2.1 billion/year for dialysis plus € 338 million for indirect costs. Aim of the present analysis was to explore socio-economical variables in the management of CKD, and assess direct and indirect health costs and NHS resources consumption. The overall cost for patients in dialysis is about 44,000 €/years for hemodialysis and 30,000 €/years for peritoneal dialysis with different resources consumption over the different stage disease. The possibility of reducing the progression of renal damaging and beginning of dialysis may induce a low expenditure for the Italian NHS.


2020 ◽  
Vol 8 (9) ◽  
pp. 1259 ◽  
Author(s):  
Shiu-Jau Chen ◽  
Shao-Cheng Wang ◽  
Yuan-Chuan Chen

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS–CoV-2), is still a global public health problem for humans. It has caused more than 10,000,000 infections and more than 500,000 deaths in the world so far. Many scientists have tried their best to discover safe and effective drugs for the treatment of this disease; however, there are still no approved standard therapeutics or effective antiviral drugs on the market. Many new drugs are being developed, and several traditional drugs that were originally indicated or proposed for other diseases are likely to be effective in treating COVID-19, but their safety and efficacy are controversial, under study, or in clinical trial phases. Fortunately, some novel antiviral strategies, such as convalescent plasma, clustered regularly interspaced short palindromic repeats (CRISPR), and mesenchymal stem cell (MSC) therapy, potentially offer an additional or alternative option or compassionate use for the people suffering from COVID-19, especially for critically ill patients, although their safety and efficacy are also under study. In this review, we explore the applications, possible mechanisms, and efficacy in successful cases using convalescent plasma, CRISPR, and MSC therapy for COVID-19 treatment, respectively. Furthermore, the perspectives and limitations of these novel antiviral strategies are evaluated.


2019 ◽  
Vol 19 (8) ◽  
pp. 567-578 ◽  
Author(s):  
Marcus Vinicius Nora de Souza ◽  
Thais Cristina Mendonça Nogueira

Nowadays, tuberculosis (TB) is an important global public health problem, being responsible for millions of TB-related deaths worldwide. Due to the increased number of cases and resistance of Mycobacterium tuberculosis to all drugs used for the treatment of this disease, we desperately need new drugs and strategies that could reduce treatment time with fewer side effects, reduced cost and highly active drugs against resistant strains and latent disease. Considering that, 4H-1,3-benzothiazin-4-one is a promising class of antimycobacterial agents in special against TB-resistant strains being the aim of this review the discussion of different aspects of this chemical class such as synthesis, mechanism of action, medicinal chemistry and combination with other drugs.


Author(s):  
VEERENDRA UPPARA ◽  
SAISEKHAR KODIVANDLA ◽  
ASHIK ALI SHAIK

Heart failure (HF) is a major global public health problem irrespective of its causes. It generates an enormous clinical, societal, and economic, health loss burden with an increase in its prevalence reaching an epidemic proportion. The morbidity and mortality associated with heart failure are increasing the health-related burdens worldwide, especially in low- and middle-income countries. This review highlights the trends in HF burden, the clinical spectrum of HF, and the importance of neurohormonal pathways and the evolution of angiotensin receptor neprilysin inhibition in HF with updated clinical practice guidelines.


2016 ◽  
Vol 27 (1) ◽  
pp. 31-35
Author(s):  
Montosh Kumar Mondal ◽  
Beauty Rani Roy ◽  
Shibani Banik ◽  
Debabrata Banik

Medication error is a major cause of morbidity and mortality in medical profession . There is an increasing recognition that medication errors are causing a substantial global public health problem, as many result in harm to patients and increased costs to health providers.Anaesthesia is now safe and routine, yet anaesthetists are not immune from making medication errors and the consequences of their mistakes may be more serious than those of doctors in other specialties. Steps are being taken to determine the extent of the problem of medication error in anaesthesia. In this review, incidence, types, risk factors and preventive measures of the medication errors are discussed in detail.Journal of Bangladesh Society of Anaesthesiologists 2014; 27(1): 31-35


Sign in / Sign up

Export Citation Format

Share Document